Cynthia Aristei

Summary

Affiliation: University of Perugia
Country: Italy

Publications

  1. doi request reprint PET and PET-CT in radiation treatment planning for lung cancer
    Cynthia Aristei
    Radiation Oncology Section, Department of Surgical, Radiological and Odontostomatological Sciences, University of Perugia, Ospedale Santa Maria della Misericordia, Sant Andrea delle Fratte, 06156 Perugia, Italy
    Expert Rev Anticancer Ther 10:571-84. 2010
  2. ncbi request reprint Outcome of a phase II prospective study on partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy
    Cynthia Aristei
    Radiation Oncology Section, University of Perugia and Santa Maria della Misericordia Hospital, Italy Electronic address
    Radiother Oncol 108:236-41. 2013
  3. doi request reprint Expander/implant breast reconstruction before radiotherapy: outcomes in a single-institute cohort
    C Aristei
    Radiation Oncology Section, Department of Surgery, Radiology and Dentistry, University of Perugia and Santa Maria della Misericordia Hospital, Sant Andrea delle Fratte, 06156, Perugia, Italy
    Strahlenther Onkol 188:1074-9. 2012
  4. doi request reprint Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Policlinico Monteluce, Perugia, Italy
    Cancer Genet Cytogenet 192:24-9. 2009
  5. doi request reprint Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study
    C Aristei
    Department of Surgical, Radiological and Odontostomatological Sciences, Radiation Oncology Section, University of Perugia, Perugia, Italy
    Ann Oncol 22:842-7. 2011
  6. ncbi request reprint Radiotherapy in Italy after conservative treatment of early breast cancer. A survey by the Italian Society of Radiation Oncology (AIRO)
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Italy
    Tumori 94:333-41. 2008
  7. doi request reprint Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study
    C Aristei
    Institute of Radiation Oncology, University of Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy
    Eur J Surg Oncol 35:144-50. 2009
  8. ncbi request reprint Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Italy
    Radiother Oncol 90:43-7. 2009
  9. doi request reprint Conformal postoperative radiotherapy in patients with positive resection margins and/or pT3-4 prostate adenocarcinoma
    Rita Bellavita
    Institute of Radiation Oncology, General Hospital and Perugia University, Perugia, Italy
    Int J Radiat Oncol Biol Phys 84:e299-304. 2012
  10. ncbi request reprint Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors
    Stefania Gori
    Medical Oncology Division, Azienda Ospedaliera Perugia, Via Dottori 1, Perugia, Italy
    Oncologist 12:766-73. 2007

Collaborators

Detail Information

Publications17

  1. doi request reprint PET and PET-CT in radiation treatment planning for lung cancer
    Cynthia Aristei
    Radiation Oncology Section, Department of Surgical, Radiological and Odontostomatological Sciences, University of Perugia, Ospedale Santa Maria della Misericordia, Sant Andrea delle Fratte, 06156 Perugia, Italy
    Expert Rev Anticancer Ther 10:571-84. 2010
    ..In non-small-cell lung cancer, PET appears to improve sparing of organs at risk and reduce the risk of toxicity; prescribed doses can be increased. Data are scarce on small-cell lung cancer...
  2. ncbi request reprint Outcome of a phase II prospective study on partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy
    Cynthia Aristei
    Radiation Oncology Section, University of Perugia and Santa Maria della Misericordia Hospital, Italy Electronic address
    Radiother Oncol 108:236-41. 2013
    ..We report the 5 year results of a phase II prospective study with PBI using interstitial multi-catheter high-dose-rate brachytherapy (ClinicalTrials.gov Identifier: NCT00499057)...
  3. doi request reprint Expander/implant breast reconstruction before radiotherapy: outcomes in a single-institute cohort
    C Aristei
    Radiation Oncology Section, Department of Surgery, Radiology and Dentistry, University of Perugia and Santa Maria della Misericordia Hospital, Sant Andrea delle Fratte, 06156, Perugia, Italy
    Strahlenther Onkol 188:1074-9. 2012
    ..Radiotherapy (RT) of reconstructed breasts was associated with major complications and poor cosmetic outcome. The present study assessed complication rates, the link between risk factors and prosthesis removal, as well as cosmetic outcomes...
  4. doi request reprint Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Policlinico Monteluce, Perugia, Italy
    Cancer Genet Cytogenet 192:24-9. 2009
    ..The increased SCE levels in patients treated with CTx may be due to a synergic effect of smoking and chemotherapy...
  5. doi request reprint Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study
    C Aristei
    Department of Surgical, Radiological and Odontostomatological Sciences, Radiation Oncology Section, University of Perugia, Perugia, Italy
    Ann Oncol 22:842-7. 2011
    ....
  6. ncbi request reprint Radiotherapy in Italy after conservative treatment of early breast cancer. A survey by the Italian Society of Radiation Oncology (AIRO)
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Italy
    Tumori 94:333-41. 2008
    ..Furthermore, results are compared with an earlier survey in northern Italy and international reports...
  7. doi request reprint Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study
    C Aristei
    Institute of Radiation Oncology, University of Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy
    Eur J Surg Oncol 35:144-50. 2009
    ..To investigate, in a phase II prospective study, the efficacy of partial breast irradiation administered with high-dose-rate brachytherapy...
  8. ncbi request reprint Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy
    Cynthia Aristei
    Department of Radiation Oncology, University of Perugia, Italy
    Radiother Oncol 90:43-7. 2009
    ..We applied image-guidance using computed tomography (CT) for pre-implant PTV definition and post-implant dosimetry...
  9. doi request reprint Conformal postoperative radiotherapy in patients with positive resection margins and/or pT3-4 prostate adenocarcinoma
    Rita Bellavita
    Institute of Radiation Oncology, General Hospital and Perugia University, Perugia, Italy
    Int J Radiat Oncol Biol Phys 84:e299-304. 2012
    ..To evaluate outcome and toxicity of high-dose conformal radiotherapy (RT) after radical prostatectomy...
  10. ncbi request reprint Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors
    Stefania Gori
    Medical Oncology Division, Azienda Ospedaliera Perugia, Via Dottori 1, Perugia, Italy
    Oncologist 12:766-73. 2007
    ..A higher incidence of central nervous system (CNS) metastases in HER-2-positive metastatic breast cancer (MBC) has recently been reported...
  11. ncbi request reprint Oxaliplatin with raltitrexed and preoperative radiotherapy in T3-T4 extraperitoneal rectal cancer. A dose finding study
    Marco Lupattelli
    Radiation Oncology Center, University and Hospital of Perugia, Perugia, Italy
    Tumori 92:474-80. 2006
    ..The aim of the study was thus to determine the recommended dose of oxaliplatin concomitantly administered with raltitrexed and concurrent preoperative radiotherapy in patients with stage II-III extraperitoneal rectal cancer...
  12. doi request reprint In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study
    C Aristei
    Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy
    Bone Marrow Transplant 48:908-14. 2013
    ..Most Centres adopted a hyperfractionated schedule that is used worldwide (12 Gy in six fractions over 3 days), which appears to have become standard. TBI doses impacted significantly upon relapse rates...
  13. doi request reprint EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review
    Vincenzo Valentini
    Department of Radiation Oncology, Cattedra di Radioterapia, Universita Cattolica S Cuore, Rome, Italy
    Radiother Oncol 110:195-8. 2014
    ..The European Registration of Cancer Care (EURECCA) drew up documents to standardize management and care in Europe and aid in decision-making...
  14. doi request reprint Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line
    Isabella Palumbo
    Radiation Oncology Section, Department of Surgical, Radiological and Odontostomatological Sciences, University of Perugia, Ospedale Santa Maria della Misericordia, Sant Andrea delle Fratte, 06156, Perugia, Italy
    Int J Colorectal Dis 29:31-41. 2014
    ..Results were promising. To elucidate the molecular and biological effects, we replicated the schedule in the LoVo human colorectal adenocarcinoma cell line...
  15. ncbi request reprint T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study
    Elisabetta Perrucci
    Radiotherapy Oncology, Policlinico Hospital and University of Perugia, Italy
    Tumori 90:379-86. 2004
    ..The incidence of locoregional relapses and the survival correlated with the number of positive nodes were recorded for each treatment arm...
  16. ncbi request reprint Breast-conserving therapy for stage I-II breast cancer in elderly women
    Bruno Cutuli
    Department of Radiation Oncology, Polyclinique de Courlancy, 38 rue de Courlancy, Reims 51100, France
    Int J Radiat Oncol Biol Phys 60:71-6. 2004
    ..To assess breast-conserving therapy results in elderly patients with early-stage breast cancer (clinical Stage I-II)...
  17. ncbi request reprint Lymphatic drainage and CTV in breast cancer
    Luigia Nardone
    Divisione di Radioterapia, Universita Cattolica del S Cuore, Policlinico A Gemelli, Roma, Italy
    Rays 28:303-9. 2003
    ..In a near future, IMRT should be able to markedly improve the dose homogeneity to target with consequent lower cardiopulmonary toxicity...